The global Cardiac Implantable Electronic Device Market Growth Accelerated by Strong Demand for Advanced Cardiac Implants
Cardiac implantable electronic devices help regulate the abnormal heart rhythm and prevent sudden cardiac arrest in patients by continuously monitoring the function of the heart and provide electrical pulses when required. Advancements in technology have enabled the development of new generation implantable devices with improved features such as enhanced battery life, wireless connectivity, and compact size. Additionally, rising prevalence of cardiovascular diseases and surge in demand for effective treatment therapies have propelled the adoption of cardiac implants globally.
The
global Cardiac Implantable Electronic Device Market is estimated to be valued
at US$ 28.1 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted
in a new report published by Coherent Market Insights.
Market key trends:
The strong demand for advanced cardiac implants has been a key growth trend
in the cardiac
implantable electronic device market size. Factors such as increasing
technological innovations leading to development of miniaturized devices with
longer battery life and improved therapeutic efficacy have boosted popularity
of next-generation cardiac implants. Additionally, growing focus of leading
manufacturers on unveiling novel product offerings such as implantable
cardioverter defibrillators (ICDs) and cardiac resynchronization therapy
defibrillators (CRT-Ds) with wireless communication capabilities are helping
expand the market reach. Such state-of-the-art implants with remote monitoring
features allow timely intervention and enhanced management of cardiac
conditions, thereby augmenting the market growth.
Segment Analysis:
Cardiac Implantable Electronic Device (CIED) Market is segmented by product
type into implantable pacemakers, implantable cardiac resynchronization therapy
devices (CRT-D), and implantable cardioverter defibrillators (ICDs). Among
these, the implantable cardioverter defibrillators segment dominated the market
in 2023 and is projected to continue its dominance during the forecast period.
ICDs are highly recommended for patients with an abnormal heartbeat, as they
can deliver electrical pulses or shocks to regulate life-threatening heart
rhythms. The rising prevalence of cardiovascular diseases is driving the
adoption of ICDs.
Key Takeaways:
The global Cardiac Implantable Electronic Device market is expected to witness
high growth. The global Cardiac Implantable Electronic Device Market is
estimated to be valued at US$ 28.1 Bn in 2023 and is expected to exhibit a CAGR
of 7.8% over the forecast period 2023 to 2030.
Europe
currently holds the largest share of the CIED market and is projected to
continue its dominance during the forecast period. The major factors driving
the market in Europe include the rising elderly population, growing prevalence
of cardiovascular diseases, developed healthcare infrastructure, and growing
awareness regarding treatment options. North America is projected to be the
fastest growing regional market during the forecast period due to rapidly
increasing healthcare expenditures and rising adoption of advanced treatment
devices in the region.
Key players related content comprises Key players operating in the Cardiac
Implantable Electronic Device market are Medtronic, Biotronik, Boston
Scientific Corporation, Pacetronix. Medtronic is currently the global leader in
the CIED market with over 30% market share. It offers a wide range of
implantable pacemakers, ICDs, and CRT devices. Biotronik also has a significant
presence globally and offers a complete portfolio of implants, leads, and
devices delivering cardiac rhythm management.
Get
more insights on this topic: https://www.newsstatix.com/cardiac-implantable-electronic-device-market-share-and-opportunity-analysis-2023-2030/
Comments
Post a Comment